The present invention relates generally to medical devices and to methods for making such devices. In particular, but not by way of limitation, the present invention relates to an infusion set, patch pump or other on-body medical device having an adhesive patch which is secured to the medical device by an overmolding process during manufacture of the medical device or during manufacture of a portion of the medical device.
In the management of diabetes, insulin can be administered to a user on a continuous basis using a programmable infusion pump. The pump is small, portable and battery-operated, and can be worn or carried inconspicuously by the user. The pump is attached by a length of tubing to an infusion set, which is a disposable body-worn device having a skin-adhering base, a fluid connector, and a rigid needle or flexible catheter that conducts the insulin into the subcutaneous or intradermal layer of the user's skin. A flexible adhesive patch or pad on the bottom of the infusion set base allows for temporary skin attachment during the period (typically a few days) that the infusion set remains in place before it is removed and replaced for sanitary reasons.
Another type of insulin infusion device, known as a patch pump, has also come into use. Unlike a conventional infusion pump, a patch pump is an integrated device that combines most or all of the required components in a single housing and does not require the use of a separate infusion set or connecting tubing. A patch pump adheres directly to the skin, contains insulin in an internal reservoir, and delivers the insulin via an integrated subcutaneous catheter. As in the case of an infusion set, a patch pump typically includes a flexible adhesive patch on its bottom surface to allow for temporary skin attachment at the infusion site.
The flexible adhesive patch is typically made of a thin fibrous material, similar to a medical dressing, but with adhesive layers on both sides. On the skin contact side, an adhesive suitable for medical or surgical use is provided, and is covered by a removable backing layer or release liner made of silicone-coated kraft paper. The release liner is removed by the user before attaching the infusion set or patch pump to the skin. The skin contact adhesive must be sufficiently strong to secure the infusion set or patch pump to the skin, but must also allow for removal of the device without damaging the skin. On the device side, a different adhesive is used, one which provides for permanent attachment between the patch and the base of the infusion set or patch pump.
Unfortunately, the need to provide two different adhesives complicates the design and manufacture of the patch, and the selection of adhesives and patch materials is limited because not all adhesives and patch materials are compatible with each other. In addition, the manufacturing process for the infusion set or patch pump may require that the adhesive patch be dispensed from a continuous roll for handling by automated equipment. This may impose additional requirements on the types of adhesives that can be used.
In accordance with the present invention, an adhesive patch is secured to an infusion set, patch pump or other on-body medical device by an overmolding process during manufacture of the medical device, or during manufacture of a portion of the medical device, without the need for a separate adhesive. This provides a more secure connection between the patch and the medical device, and reduces the required number of adhesive layers from two (skin attachment side and device attachment side) to one (skin attachment side only), thereby simplifying the design and manufacture of the patch.
In one aspect, the present invention provides an on-body medical device comprising a molded plastic base and a flexible fibrous, textured, perforated or porous patch having a skin-contacting adhesive on one side and an opposite side overmolded with the base. In another aspect, the present invention provides a method of making an on-body medical device comprising injection molding a plastic base over a flexible fibrous, textured, perforated or porous patch in a mold cavity.
In an embodiment of the present invention, molten plastic is injected into a medical device mold cavity containing the adhesive patch during an injection molding operation, similar to the manner in which in-mold labeling is carried out with other types of products. Unlike an in-mold label, however, the adhesive patch is made of a fibrous, textured, perforated or porous material having many small interstices, openings or cavities into which the plastic material flows during the molding operation. When the plastic material cools and hardens, this creates a very strong bond between the adhesive patch and the medical device without the need for an adhesive.
Aspects and advantages of embodiments of the invention will be more readily appreciated from the following detailed description, taken in conjunction with the accompanying drawings, in which:
Reference will now be made in detail to embodiments of the present invention, which are illustrated in the accompanying drawings, wherein like reference numerals refer to like elements throughout. The embodiments described herein exemplify, but do not limit, the present invention by referring to the drawings.
It will be understood by one skilled in the art that this disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the drawings. The embodiments herein are capable of other embodiments, and capable of being practiced or carried out in various ways. Also, it will be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless limited otherwise, the terms “connected,” “coupled,” and “mounted,” and variations thereof herein are used broadly and encompass direct and indirect connections, couplings, and mountings. In addition, the terms “connected” and “coupled” and variations thereof are not restricted to physical or mechanical connections or couplings. Further, terms such as “up”, “down”, “bottom”, and “top” are relative, and are employed to aid illustration, but are not limiting.
As shown in
The adhesive patch 16 and release liner 18 are formed with two sets of identical, aligned holes 32, 34 and 36, 38 as shown more clearly in
As shown in
More specifically, the rigid inner hub 40 is injection-molded in a first shot, and the flexible outer disk 42 is molded in a second shot during which the molten plastic material of the outer disk 42 flows around the rim 44 and through the holes 46. The shape of the rim 44 provides a double overlapping joint with the material of the flexible outer disk 42, and the holes 46 provide additional bonding surface area and additional mechanical interlocking.
The flexible outer disk 42 provides improved comfort and mobility of the infusion set base assembly 14 because it moves with the user during physical activity while minimizing contact of the rigid inner hub 40 with the user. The flexible outer disk 42 is attached to the adhesive patch assembly 19 by overmolding during the second shot of the aforementioned two-shot injection molding process.
The two-shot injection molding process is described in more detail in the flowchart of
In step 56, the mold is closed (i.e., the upper and lower mold halves are brought together) in preparation for the first (hard) molding shot. This shot forms the rigid inner hubs 40 of
In step 58, molten plastic material is injected under pressure into the cavities 52 to perform the hard shot. In the illustrated example, eight rigid inner hubs 40 are formed simultaneously during the first molding shot.
In step 60, the mold is opened with the fully formed inner hubs 40 retained in the upper half of the mold. The mold is then indexed by rotating the upper mold half by 180 degrees about a vertical axis with respect to the lower mold half. This aligns the upper mold cavities containing the fully formed inner hubs 40 with the empty lower mold cavities 54 in which the flexible outer disks 42 will be formed and overmolded with the rigid inner hubs 40 in the second (soft) molding shot.
In step 62, robotic end-of-arm tools are used to place the adhesive patch assemblies 19 into the open mold cavities 54 as shown in
In step 64, the mold is again closed in preparation for the second (soft) molding shot. This shot forms the flexible outer disks 42 of
In step 66, the soft molding shot is performed by injecting molten plastic material into the mold cavities 54 from gates (not shown) located beneath the patch assemblies 14. The holes 36, 38 in the adhesive patches 16 and release liners 18 are aligned with these gates. The molten plastic material passes through the holes 36, 38 to form the flexible outer disks 42 in overlying interlocked relationship with the previously formed rigid inner hubs 40 as shown in
In step 68, the completed base assemblies 14 are removed from the mold for further assembly and packaging steps. This includes the addition of the introducer needle hub 12, catheter 20, needle guard 22 and related components that form the completed infusion set 10 of
It will be appreciated that the rotational indexing described in step 60 above allows the two sets of mold cavities 52, 54 to be operated simultaneously. This is done in a staggered manner so that hub-forming hard shots are performed on one side of the mold while disk-forming soft shots over previously-formed hubs are performed on the other side of the mold. It will also be appreciated that base assemblies for patch pumps and other types of on-body medical devices can be made using an injection molding process similar to that illustrated in
In embodiments of the invention, the patch assembly 19 can be die-cut from commercially available 3M™ Medical Nonwoven Tape (Product No. 1776). In this product, the patch material 16 is a ˜11.5 mil (0.3 mm) thick white spunlace nonwoven tape made of randomly oriented polyester fibers, the skin-contact adhesive 17 is an acrylate adhesive developed for medical/surgical use, and the release liner 18 is 83 lb. poly-coated Kraft paper of 6 mil (0.15 mm) thickness with a silicone release layer on both sides. Another suitable material is 3M™ Single Coated, Extended Wear Nonwoven Medical Tape (Product No. 4076). Still other materials that can be used are various single-coated medical tapes that are available from the Medical Materials and Technologies division of 3M Company. Other types of fibrous, textured, perforated or porous materials that are able to withstand the heat and pressure of the injection molding process can also be used for the adhesive patch 16 in the practice of the present invention.
In embodiments of the invention, the rigid inner hub 40 and flexible outer disk 42 may be made of any plastic materials that are suitable for injection molding. The rigid inner hub 40 is preferably made from a polyester blended material or polycarbonate, although this is not required. The flexible outer disk 42 is preferably made from a thermoplastic elastic material, some examples of which are listed in the table below Materials which allow for molding of the flexible outer disk 42 at lower temperatures are preferred in order to avoid adverse effects on the skin contact adhesive 17 provided between the patch 16 and the release liner 18.
Although only a few embodiments of the present invention have been shown and described, the present invention is not limited to the described embodiments. For example, it may be possible to use compression molding for either or both of the molding steps, instead of injection molding. It will be appreciated by those skilled in the art that other changes may also be made to the disclosed embodiments without departing from the scope of the invention. In addition, any of the embodiments, features and/or elements disclosed herein may be combined with one another to form various additional combinations not specifically disclosed, as long as the embodiments, features and/or elements being combined do not contradict each other. All such changes and combinations are considered to be within the scope of the invention as defined by the appended claims and their equivalents.
Number | Name | Date | Kind |
---|---|---|---|
5384174 | Ward et al. | Jan 1995 | A |
6121611 | Lindsay et al. | Sep 2000 | A |
6134461 | Say et al. | Oct 2000 | A |
6175752 | Say et al. | Jan 2001 | B1 |
6560471 | Heller et al. | May 2003 | B1 |
D488230 | Ignotz et al. | Apr 2004 | S |
6746582 | Heller et al. | Jun 2004 | B2 |
7070580 | Nielsen | Jul 2006 | B2 |
7129389 | Watson | Oct 2006 | B1 |
7621395 | Mogensen et al. | Nov 2009 | B2 |
7850658 | Faust et al. | Dec 2010 | B2 |
8790311 | Gyrn | Jul 2014 | B2 |
9501043 | Heck | Nov 2016 | B2 |
9795777 | Sonderegger et al. | Oct 2017 | B2 |
9889255 | Sonderegger et al. | Feb 2018 | B2 |
20060015063 | Butikofer | Jan 2006 | A1 |
20080167620 | Adams et al. | Jul 2008 | A1 |
20080278332 | Fennell et al. | Nov 2008 | A1 |
20100198034 | Thomas et al. | Aug 2010 | A1 |
20110060196 | Stafford | Mar 2011 | A1 |
20140316379 | Sonderegger | Oct 2014 | A1 |
20150241288 | Keen | Aug 2015 | A1 |
20160095597 | Belson et al. | Apr 2016 | A1 |
20160310665 | Hwang et al. | Oct 2016 | A1 |
20160324470 | Townsend | Nov 2016 | A1 |
Number | Date | Country |
---|---|---|
2692374 | Feb 2014 | EP |
WO-2008082854 | Jul 2008 | WO |
WO-2015095639 | Jun 2015 | WO |
WO-2016026028 | Feb 2016 | WO |
Entry |
---|
3M Science. Applied to Life. Adhesive for when duration matters (Aug. 2017). |
3M Technical Information Sheet—Product No. 1776—3M TM Medical Nonwoven Tape (2013). |
Number | Date | Country | |
---|---|---|---|
20190176380 A1 | Jun 2019 | US |